You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 133 No. 2, February 1974 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Pulmonary Alveolar Proteinosis

James B. McClenahan, MD; Rowena Mussenden, MD

Arch Intern Med. 1974;133(2):284-287.


Abstract



Intra-alveolar material from three patients with pulmonary alveolar proteinosis (PAP) who underwent therapeutic pulmonary lavage was studied to determine its composition and surface properties. This material was compared with material lavaged from "normal" lungs obtained from patients dying of acute nonpulmonary causes. The intra-alveolar material from PAP patients contains lipid and protein. Classes of lipids, their percent distribution, and distribution of the individual phospholipids were the same in PAP-patient material and controls. Serum proteins were found in amounts characteristic of normal serum. The PAP material exhibited decreased surface activity; after exposure to ethyl alcohol, normal surface activity was recorded. The intra-alveolar material in pulmonary alveolar proteinosis represents an accumulation of modified normal surfactant and serum, rather than abnormal lipids or proteins, or disproportionate quantities of normal lipids.



Author Affiliations



Palo Alto, Calif

From the Department of Internal Medicine, Stanford University School of Medicine, and the Palo Alto Medical Research Foundation, Palo Alto, Calif.


Footnotes



Received for publication Oct 12,1972; accepted Dec 4.

Read before the American Federation for Clinical Research, Carmel, Calif, Feb 4, 1972.

Reprint requests to Palo Alto Medical Research Foundation, 860 Bryant St, Palo Alto, CA 94301 (Dr. McClenahan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
Seymour and Presneill
Am. J. Respir. Crit. Care Med. 2002;166:215-235.
ABSTRACT | FULL TEXT  

Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis
Shah et al.
Thorax 2000;55:67-77.
FULL TEXT  

Quantity and Structure of Surfactant Proteins Vary Among Patients with Alveolar Proteinosis
DOYLE et al.
Am. J. Respir. Crit. Care Med. 1997;157:658-664.
ABSTRACT | FULL TEXT  

The Clinical and Physiological Effect of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Ten-Year Experience
Selecky et al.
Ann. Thorac. Surg. 1977;24:451-461.
ABSTRACT  

Pulmonary Alveolar Proteinosis
Cugell
JAMA 1975;234:80-80.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.